CHICAGO, July 5, 2024
/PRNewswire/ -- The global contrast medial injectors market is
expected to grow from USD 1.6 billion
in 2024 to USD 2.3 billion by 2029,
at a CAGR of 8.0%. Key drivers include the rising incidence of
cancer and cardiovascular diseases, especially among the aging
population, and advancements in injector technology that enhance
diagnostic accuracy and early detection. Increased disposable
incomes and expanding healthcare access in emerging markets also
contribute to this growth. However, the high cost of contrast media
injectors poses a restraint, particularly for smaller healthcare
facilities in emerging economies. Opportunities arise from rising
healthcare expenditure in countries like China, India,
Brazil, and Mexico, driven by government initiatives and
increasing demand for advanced healthcare services. Challenges
include a shortage of trained professionals to operate advanced
medical devices. The market is segmented by product, type,
application, and end user, with consumables, dual-head injectors,
radiology applications, and hospitals holding the largest shares in
their respective categories. North
America is expected to remain the largest market due to its
technological leadership and robust healthcare infrastructure. Key
market players include Bayer AG, Bracco Imaging S.p.A., Guerbet,
MEDTRON AG, Ulrich GmbH & CO. KG, and Nemoto Kyorindo Co.,
Ltd.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959
Browse in-depth TOC on "Contrast Media Injectors
Market"
180 - Tables
50 - Figures
206 -
Pages
Key Players in the Contrast Media Injectors Market: A
Competitive Landscape
The contrast media injectors market is consolidated, with key
players adopting strategies such as partnerships, acquisitions, and
expansions to maintain their market positions. As of 2023, the
major players in this market include Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), Guerbet (France), Medtron AG (Germany), Ulrich GmbH & Co. KG
(Germany), and Nemoto Kyorindo
(Japan).
Bayer AG (Germany): Global
Leader in Radiology Business
Bayer Pharma, a subgroup of Bayer AG, focuses on the radiology
business and operates in over 100 countries worldwide. The company
offers digital solutions, injection systems, and contrast agents,
along with related accessories and consumables for contrast media
injectors. Bayer emphasizes R&D in pharmaceuticals to address
high medical needs and leverages its global presence to maintain a
strong market position.
Bracco Imaging S.p.A. (Italy): Innovator in Diagnostic
Imaging
Bracco Imaging S.p.A., part of the Bracco Group, is a global
leader in diagnostic imaging. The company manufactures and
commercializes contrast media injectors and software, including
contrast agents. Bracco focuses on strategic collaborations and
innovation for organic growth. Notably, Bracco partnered with
Ulrich GmbH to market its MR injector in the US. The company
operates manufacturing sites in multiple regions, maintaining a
presence in over 100 countries with a robust R&D capability and
strong product portfolio.
Guerbet (France): Pioneer in
Contrast Media Injectors
Guerbet offers contrast media injectors and related accessories
through its Diagnostic Imaging segment. The company prioritizes
launching innovative solutions to enhance patient outcomes.
Committed to R&D, Guerbet introduced OptiProtect 3S in 2021 to
support imaging centers. Operating in Europe, Asia,
and the Americas, Guerbet distributes its products in about 80
countries, continually driving market growth through technological
advancements and new product launches.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=96046959
Product Segmentation: Consumables Lead the Market
The contrast media injectors market is segmented based on
product into injector systems, consumables, and accessories. The
consumables segment is expected to hold the major market share in
2023, driven by the cost-effectiveness of treatments and increasing
awareness of the benefits of contrast-mediated procedures.
Type Segmentation: Dual-Head Injectors Dominate
By type, the market is segmented into dual-head, single-head,
and syringeless injectors. In 2023, the dual-head segment held a
significant market share, supported by a favorable reimbursement
scenario in developed countries and the advantages of dual-head
injectors over other types.
Application Segmentation: Radiology Holds a Significant
Share
The contrast media injectors market is segmented by application
into interventional cardiology, radiology, and interventional
radiology. In 2023, the radiology segment held a significant market
share, driven by the growing global prevalence of cancer and
increasing regulatory approvals of contrast agents.
End User Segmentation: Hospitals Lead the Market
Regarding end users, the market is fragmented into hospitals and
diagnostic imaging centers. The hospitals segment attributed the
major share of the market in 2023, driven by a rising focus on
healthcare research and increasing funding opportunities from
public and private organizations.
Geographical Insights: North America Leads with Significant
Share
The contrast media injectors market is segmented by region into
North America, Europe, Asia
Pacific, Latin America, and
MEA. In 2023, North America
accounted for the major market share, followed by Europe and APAC. This significant share is
attributed to the increasing installation of diagnostic imaging
equipment, a rising number of contrast-mediated scans, a higher
incidence of target diseases, and expanding research
activities.
For more information, inquire now! Inquire Now
Related Reports:
Contrast Media Market
Preclinical Imaging Market
Diagnostic Imaging Market
Nuclear Medicine Market
Diagnostic Imaging Services Market
Get access to the latest updates on Contrast Media Injectors
Companies and Contrast Media Injectors Market
Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/global-contrast-media-injectors-market-to-reach-usd-2-3-billion-by-2029-driven-by-automated-solutions--marketsandmarkets-302189887.html
SOURCE MarketsandMarkets